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9-Norbornyl-6-chloropurine (NCP) is a representative of a series of antienteroviral bicycle derivatives
with selective cytotoxicity towards leukemia cell lines. In this work we explored the mechanism of the
antileukemic activity of NCP in T-cell lymphoblast cells (CCRF-CEM). Speciﬁcally, we searched for a po-
tential link between its ability to induce cell death on the one hand and to modulate intracellular glu-
tathione (GSH) that is necessary to its metabolic transformation via glutathione-S-transferase on the
other hand. We have observed that GSH levels decreased rapidly in NCP-treated cells. Despite a complete
regeneration following 24 h of incubation with NCP, this profound drop in cellular GSH content triggered
ER stress, ROS production and lipid peroxidation leading to the loss of mitochondrial membrane po-
tential (MMP). These events induced concentration-dependent cell cycle arrest in G2/M phase and
apoptosis. Both MMP loss and apoptosis were reversed by sulfhydryl-containing compounds (GSH, N-
acetyl-L-cysteine). Furthermore, we have also shown that NCP-induced GSH decrease activated the Nrf2
pathway and its downstream targets NAD(P)H:quinone oxidoreductase (NQO-1) and glutamate cysteine
ligase modiﬁer subunit (GCLm), thus explaining the fast restoration of GSH pool and ROS decrease.
Importantly, we conﬁrmed that the cell death-inducing properties of the compounds were co-dependent
on their ability to diminish cellular GSH level by analyzing the relationships between the GSH-depleting
potency and cytotoxicity in a series of other norbornylpurine analogs. Altogether, the results demon-
strated that in CCRF-CEM cells NCP triggered apoptosis through GSH depletion-associated oxidative and
ER stress and mitochondrial depolarization.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
9-Norbornylpurine derivatives are a class of in-house synthe-
sized compounds originally developed as antienteroviral drugs
with enhanced activity against Coxsackievirus B3 [1–5].
9-Norbornyl-6-chloropurine (NCP, compound 1, Fig. 1) re-
presents the prototype structure of the series and has been foundInc. This is an open access article u
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líková-Kaiserová).to possess signiﬁcant cytostatic activity, particularly towards hu-
man leukemia cell lines. This suggested the potential of these
compounds as prospective anticancer drugs as well. Although
9-norbornylpurines could be regarded as carbocyclic nucleoside
analogs, our previous in vitro experiments with NCP revealed that
they do not behave as nucleoside analogs, but rather as substituted
nucleobases. The lipophilic norbornane moiety in fact does not
mimic the sugar but provides the compounds with the advanta-
geous pharmacokinetic properties as exempliﬁed by excellent
membrane permeability in intracellular transport assays in CCRF-
CEM (T-lymphoblast) cells as well as in the transepithelial Caco-2
assay [6]. Previously, we have also demonstrated the essential role
of glutathione (GSH) in the metabolic transformation of NCP to
polar conjugates (NCP-GS) in CCRF-CEM cells. The reaction was
found to be strictly dependent on glutathione-S-transferase (GST)
activity and cellular GSH (the absence of metabolite formation in
BSO-treated cells). The conjugates were readily formed and ex-
creted from the cells. They also exhibited lower toxicity comparednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Structures of substituted 9-norbornyl-6-chloropurines. 1: 9-[(1R*, 2R*, 4S*)-bicyclo[2.2.1]hept-2-yl]-6-chloro-9H-purine (NCP), 2: 2-(((1R*, 2R*, 4R*, 5S*)-5-(6-chloro-
9H-purin-9-yl)bicyclo[2.2.1]heptan-2-yl)oxy)ethanol, 3: 6-chloro-9-((1R*, 2S*, 4R*)-5-ﬂuorobicyclo[2.2.1]hept-5-en-2-yl)-9H-purine, 4: (1s, 3r, 5R*, 7S*)-3-(6-chloro-9H-
purin-9-yl)adamantan-1-ol, 5: 6-chloro-9-[(1R*, 7R*, 8S*)-4-thiatricyclo[5.2.1.02,6]deca- 2,5-dien-8-yl-9H-purine, 6: 9-(bicyclo[2.2.1]heptan-1-yl)-6-chloro-9H-purine, 7: 9-
(bicyclo[3.2.1]octan-1-yl)-6-chloro-9H-purine, 8: 9-((1S*, 2S*, 4R*)-bicyclo[2.2.1]heptan-2-yl)-6-chloro-8-phenoxy-9H-purine 9: 9-((1S*, 2S*, 4R*)-bicyclo[2.2.1]heptan-2-yl)-
6-chloro-N-methyl-9H-purin-8-amine.
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whether the cytotoxic effects of NCP are directly linked to its
ability to cause GSH depletion (resulting from NCP metabolism)
and consequent oxidative stress or whether a distinct mechanism
is involved.
Although physiological level of reactive oxygen species (ROS)
serves for the signalling and normal functioning in the cells, can-
cer cells, compared to normal cells, are under increased oxidative
stress [8]. This may provide an opportunity to kill cancer cells
based on their vulnerability to further ROS increase. The natural
source of ROS in cells are enzymatic reactions (e.g., mitochondrial
respiratory chain reactions, arachidonic acid pathway, cytochrome
P450 family and those involving glucose oxidase, amino acid oxi-
dase, xanthine oxidase, NADP/NADPH oxidase or NO synthases)
[9]. These reactions take place in mitochondria, endoplasmic re-
ticulum (ER), plasma membrane and cytosol [10]. ROS formation is
balanced by a highly efﬁcient system of antioxidants, including
both enzymatic and nonenzymatic pathways [11]. GSH serves as a
major regulator of the cellular redox homeostasis and protects the
cell against ROS and electrophiles. As a donor of –SH group, it acts
either as a direct antioxidant or indirectly as a cofactor of phase II
enzymes, such as GST [12]. GSH depletion, especially that of its
mitochondrial pool, has been described to induce apoptotic cell
death [13].
The ER represents a major protein folding site in the cell. The
accumulation of incorrectly folded proteins triggers ER stress and
activation of the unfolded protein response (UPR). The UPR com-
prises three parallel signaling pathway: PKR-like ER kinase (PERK),eukaryotic translation initiation factor 2α (eIF2α), inositol-requir-
ing protein 1α (IRE1α) and activating transcription factor 6α
(ATF6α). Because the UPR employs both protective and apoptotic
effects on cell survival upon ER stress, UPR activation may facil-
itate, as well as suppress, malignant transformation [14]. Many
studies suggest that ER regulates apoptosis both by sensitizing
mitochondria to a death stimulus and by initiating cell death
signals of its own [15,16]. ER stress has also been recognized as a
mechanism leading to tumor cell death following chemother-
apeutics. ROS have recently emerged as crucial regulators of ER
function [11] as oxidative stress and ER stress are frequently ob-
served together. ROS-mediated UPR may lead to apoptosis acti-
vation via PERK, which has been reported to be involved in mi-
tochondria-ER crosstalk [17]. Mitochondria are one of particularly
affected organelles in the apoptotic process where BCL-2 family
proteins are central regulators of apoptosis [18]. Alterations in
mitochondrial physiology, such as dissipation of the inner mem-
brane potential and/or release of intermembrane proteins, have
been described in many apoptotic responses [19]. The mitochon-
drial dysfunction is connected with several human diseases, while,
on the other hand, mitochondria represent suitable targets for
activating speciﬁc killing of cancer cells [20,21].
The transcriptional activation of the antioxidant response ele-
ments (ARE), mediated primarily by nuclear factor E2-related
factor 2 (Nrf2), is a major mechanism in cellular defense against
oxidative and electrophilic stress. Nfr2 pathway is one of the an-
tioxidant mechanisms, which can also be activated in response to
ER stress [22]. The transcription factor Nrf2 is required for the
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and glutamate cysteine ligase modiﬁer subunit (GCLm), which are
necessary for GSH biosynthesis. Nrf2 also regulates expression of
other cellular detoxifying enzymes, e.g. NAD(P)H:dehydrogenase,
quinone 1 (NQO1) [23].
The goal of this study was to elucidate the mechanism by
which NCP induces apoptosis in leukemia (CCRF-CEM) cells. Spe-
ciﬁcally, we aimed to investigate the role of GSH and oxidative
stress signaling and its consequences such as ER stress and mi-
tochondrial dysfunction in NCP-induced cell death.2. Material and methods
2.1. Materials
NCP was synthesized as described previously [24]. Stock solu-
tions were prepared by the dissolving of the compound in DMSO
at 50 mM concentration. Allopurinol (ALLO), 1-aminobenzotriazole
(ABT), BCA kit, streptomycin, penicillin G, PBS, RPMI-1640 med-
ium, RPMI-1640 Dutch modiﬁcation medium, fetal calf serum,
carbonyl cyanide 3-chlorophenylhydrazone (CCCP), caffeic acid
phenethyl ester (CAPE) diphenyleneiodonium chloride (DPI), so-
dium phenylbutyrate (4-PBA), 1,1,3,3-tetraethoxypropane (MDA),
ethylenediaminetetraacetic acid (EDTA), 2-thiobarbituric acid
(TBA), triﬂuoroacetic acid (TFA), L-glutathione reduced (GSH), L-
glutathione oxidized (GSSG), RNaseA, sulfosalicylic acid (SA),
quercetin (QUER) 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), β-
NADPH, ATP, staurosporine, 1-chloro-2,4-dinitrobenzene (CDNB),
acetonitrile, methanol, protease and phosphatase inhibitor cock-
tail, glutathione reductase (GR) from baker’s yeast (E.C 1.6.4.2, 500
UN), CHAPS and monoclonal anti-β-actin antibody were pur-
chased from Sigma–Aldrich (St. Louis, MO, USA). CM-H2DCFDA
(General Oxidative Stress Indicator), JC-1 dye (Mitochondrial
Membrane Potential Probe), Dead Cell Apoptosis Kit with Annexin
V Alexa Fluors 488 & Propidium Iodide (PI) and MitoSOX™ Red
Mitochondrial Superoxide Indicator were purchased from Ther-
moFisher Scientiﬁc (Waltham, MA USA). CaspACE™ FITC-VAD-
FMK In Situ Marker was purchased from Promega (Madison, WI,
USA). Salts for buffer preparations were purchased from Serva
(Heidelberg, Germany). Monoclonal anti-Nrf2, -NQO-1, -GCLm, -p-
eIF2α (phosphorylated form), histone H3 (H3) and -p-IRE1
(phosphorylated form) antibodies were purchased from Cell Sig-
naling Technology, Inc. (Danvers, MA, USA).
2.2. Cell culture
CCRF-CEM and BGM cells (ATCCs, UK) were grown in RPMI-
1640 and Eagle's MEM medium, respectively, supplemented with
10% (v/v) fetal calf serum, 200 mg/ml of streptomycin, 200 U/ml of
penicillin G and 4 mM glutamine. They were cultured under a
humidiﬁed atmosphere containing 5% CO2 at 37 °C. Unless other-
wise indicated, cells were seeded into the 6-well plates at a den-
sity from 6104 (for 72 h incubation) to 3105 (for 24 h in-
cubation) cells per well and left to rest overnight. 10–30 mM NCP
was then added and incubated for up to 72 h.
2.3. Cell cycle analysis
1106 NCP-treated cells were washed thoroughly with PBS
(250 g for 5 min) and resuspended in 0.5 ml of ice-cold PBS.
4.5 ml of ice-cold 80% ethanol was then added drop wise while
vortexing, ﬁxed on ice for 30 min and centrifuged at 250 g for
5 min at 4 °C. Pelleted cells were resuspended in 0.5 ml of PBS
containing PI (0.1 mg/ml), RNaseA (8.7 mg/ml) and Triton-X 100
(0.1%) and incubated for 1 h. The cellular DNA content wasdetermined by FACSFortessa (BD Biosciences, San Jose, CA). The
data were plotted as histograms and the distribution of the cell
cycle phases was analyzed using ModFit LT 3.0 (Verity Software
House, Topsham, ME).
2.4. Apoptosis determination
The phosphatidylserine externalization in the apoptotic cells
was quantiﬁed using an Alexa Fluor 488 Annexin V/Dead cell
apoptosis kit (Invitrogen (Carlsbad, CA, USA) according to the
manufacturer’s instructions. Brieﬂy, 1106 cells treated with NCP
or 1 mM staurosporine were washed thoroughly with PBS (250 g
for 5 min) and resuspended in 0.1 ml of 1 annexin-binding
buffer. Then, 5 ml of Alexa Fluor 488 Annexin V and 1 ml of PI
(100 μg/mL) were added to 100 ml of the cell suspension. Cells
were gently mixed, and incubated for 15 min at room temperature
in the dark. After that, 400 μl of 1 annexin-binding buffer was
added to each tube, and samples were analyzed by ﬂow cytometry
using FACSFortessa Cell Sorter (BD Biosciences, San Jose, CA USA).
Annexin Vþ PI cells represented an early apoptotic population.
Annexin Vþ PIþ cells represented either late apoptotic or sec-
ondary necrotic populations.
The activation of caspases in NCP-treated samples was analyzed
by means CaspACE™ In Situ Marker. 1106 cells were washed
thoroughly with PBS (250 g for 5 min) and resuspended in 0.5 ml
of 10 mM CaspACE solution in PBS. After 20 min at room tem-
perature in the dark, the samples were centrifuged at 250 g for
5 min, resuspended in 0.5 ml of HBSS and analyzed by FACS.
2.5. Glutathione determination
Total GSH content was determined according to Rahman et al.
[25]. CCRF-CEM and BGM cells were lysed in ice-cold extraction
buffer containing 0.1% Triton-X 100 and 0.6% SA in water and
centrifuged at 3000 g for 4 min at 4 °C. 20 ml of the supernatant
or standard solution (GSH and GSSG) was mixed with 120 ml of
DTNB and GR (1:1) in a 96-well plate. After 30 s, 6 ml of β-NADPH
was added and measured immediately at 412 nm using an Inﬁnite
M1000 plate reader (Tecan Systems Inc., San Jose, CA, USA). Ab-
sorbance was recorded every 15 s for 10 min.
2.6. Detection of reactive oxygen species (ROS)
CCRF-CEM cells were treated with NCP as described in 2.2 or
alternatively, the cells were pre-incubated (0.5 h) with the in-
hibitors –10 mM CCCP (the uncoupler of mitochondrial respiratory
chain), 2 mM DPI (the inhibitor of NADPH-oxidase), 0.5 mM ALLO
(the inhibitor of xanthine/xanthine oxidase), 0.25 mM ABT (the
inhibitor of CYP450), 10 mM CAPE (the inhibitor of lipoxygenase)
and 5 mM 4-PBA (the inhibitor of ER-stress) or antioxidants 3 mM
GSH, 3 mM NAC and 10 mM QUER prior to the addition of 20 mM
NCP. After the treatment, 1106 cells were washed thoroughly
with PBS (250 g for 5 min), resuspended in 0.5 ml of 1 μM
CM-H2DCF-DA solution in HBSS (for general ROS detection) and
incubated for 1 h in the dark at 37 °C or in 0.5 ml of 3.5 μM Mi-
toSOX™ solution in HBSS (for mitochondrial superoxide detection)
for 0.5 h in the dark at RT and then washed thoroughly with PBS
(250 g for 5 min). Pelleted cells were resuspended in 0.5 ml of
HBSS and analyzed by FACS.
2.7. Determination of lipid peroxidation
50 ml of cell suspension (1106 cells/ml) in PBS or MDA stan-
dard solutions was mixed with 450 ml of TBA reagent (12 mM TBA,
0.32 M H3PO4, EDTA 0.01%, 1.35 mg/ml BHT in EtOH), incubated for
1 h at 99 °C and chilled on ice. Chilled samples were extracted to
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organic phase was injected onto a Nova-Pack C18 HPLC column
(3.915 mm, Waters) and separated using the Waters Alliance HT
HPLC system with ﬂuorescent detection. The mobile phase con-
sisted of 35% methanol and 65% water with 0.05% TFA. The ﬂow
rate was 0.7 ml/min. The ﬂuorescence intensity was recorded at
λex¼532 nm and λem¼553 nm.
2.8. Protein extraction and Western blotting
NCP-treated cells were washed with PBS (250 g for 5 min)
and lysed by ice-cold RIPA buffer (107 cells/150 ml) containing
protease and phosphatase inhibitors for 30 min on ice and cen-
trifuged at 14,000 g for 30 min at 4 °C. The supernatant con-
tained whole cell extract which was used for NQO-1, GCLm and LO
activity assay. Alternatively, cells were washed with PBS (250 g
for 5 min) and re-suspended in ice-cold hypotonic buffer (10 mM
HEPES pH 7.5, 2 mM MgCl2, 25 mM KCl and fresh 1 mM DTT and
protease and phosphatase inhibitor cocktail) at 5107 cells/ml.
After 30 min NP-40 was added to 0.5% concentration, mixed gently
and centrifuged at 1000 g for 15 min at 4 °C. The supernatant
(cytosol) was removed. The pellet (nuclei) was washed with ice
cold hypotonic buffer N (10 mM HEPES pH 7.5, 2 mM MgCl2,
25 mM KCl, 250 mM sucrose and fresh 1 mM DTT, and protease
and phosphatase inhibitor cocktail) and centrifuged at 1000 g for
15 min at 4 °C. Isolated nuclei were then lysed as the whole cel-
lular extract and it was used for Nrf-2 detection.
Membrane proteins were isolated as follows: cells were wa-
shed with PBS and suspended in ice cold lysis buffer (20 mM
HEPES pH 7.0, 25 mM KCl, 25% glycerol, 2 mM EDTA, 20 mM
CHAPS) at 5107 cells/ml on ice for 30 min and centrifuged at
14,000 g for 30 min at 4 °C. The supernatant contained mem-
brane protein which was used for p-eIE2α and p-IRE1 detection.
Microsomal fraction was isolated as follows: cells were washed
with PBS (250 g for 5 min) and re-suspended in ice-cold phos-
phate buffer (0.1 M, pH¼7.4) containing 20% glycerol at 1107
cells/ml. Following the ultrasonic lysis, the lysate was centrifuged
at 20,000 g for 15 min at 4 °C. The supernatant was centrifuged
again at 105,000 g for 90 min at 4 °C. The supernatant (cytosol)
was removed and the pellet (microsomal fraction) was re-sus-
pended in ice-cold phosphate buffer (0.1 M, pH¼7.4) containing
20% glycerol (450 ml per sample). Cytosolic and microsomal frac-
tions were used for GST activity and NCP-metabolism evaluation.
The protein content in each sample was determined using the
BCA kit according to the protocols provided by the manufacture.
30 mg of protein was then loaded per well on polyacrylamide
gel, electrophoresed and electroblotted onto a PVDF membrane
(Merck, USA). Then, the membranes were blocked in 5% non-fat
dry milk in TBS containing 0.05% of Tween 20 and probed with
speciﬁc antibodies and appropriate HRP-conjugated secondary
antibodies. SuperSignals West Femto Maximum Sensitivity Che-
miluminescent Substrate (Pierce, Waltham, MA USA) was used for
signal detection by CCD camera. Densitometric analysis of blots
was performed by Quantity Ones 1-D analysis software (Bio-Rad,
Hercules, CA, USA).
2.9. Detection of mitochondrial membrane potential (MMP)
CCRF-CEM cells were treated with NCP as described in 2.2 or
alternatively, the cells were pre-incubated (0.5 h) with 10 mM
4-PBA, 3 mM GSH and 3 mM NAC prior to the addition of 20 mM
NCP. After the treatment, 1106 cells were incubated with 0.5 ml
of 2.5 μg/ml JC-1 solution in HBSS for 0.5 h in the dark at 37 °C and
then centrifuged at 250 g for 5 min. Pelleted cells were re-
suspended in 0.5 ml of HBSS and analyzed by FACS.2.10. ATP determination
Total ATP content was determined using CellTiter-Glo
s
Lumi-
nescent Cell Viability Assay kit (Madison, WI, USA) according to the
protocols provided by the manufactures. Brieﬂy, NCP-treated cells
were resuspended in HBSS solution and seeded in a 96-well plate at
a density of 2105 cells per well (50 ml). After that, 50 ml of Cell-
Titer-Glos solution was added to cell suspensions or ATP standard
solutions, incubated for 2 min at room temperature in the dark
while constantly mixing the sample and then incubated for further
10 min to stabilize luminescent signal. Luminescence was measured
using the Cytation 3 plate reader (BioTek, Germany).
2.11. HPLC analysis of NCP metabolites
20–200 mM NCP was incubated with the cytosolic and micro-
somal fractions isolated from CCRF-CEM cells (3.5 mg of proteins
per ml) and 0.5 mM GSH in 0.5 mM phosphate buffer pH 7.4 for
30 min at 37 °C. The reactions were stopped and extracted with
methanol and chilled at 20 °C for 1 h. Then the samples were
centrifuged at 8000 g for 2 min in centrifugal ﬁlter units (Ultra-
free-MC dura 0.22 mm, Millipore). The ﬁltrates (50 ml) were injected
onto the Supelcosil LC-18-S HPLC column (150 mm4.6 mm I. D.,
5 mm). Mobile phase A corresponded to 50 mM phosphate buffer
(PB) with 30% acetonitrile (v/v), mobile phase B to 50 mM PB with
10% acetonitrile (v/v) and mobile phase C to 50 mM PB. The gradient
started with 100% mobile phase C going isocratically in 5 min, fol-
lowed by steep change from C to B in 6 min, ongoing nonlinearly to
50% B in 20 min and then going linearly to 100% mobile phase A in
35 min. The ﬂow rate was 0.9 ml min1. The absorption spectra of
the eluate were recorded by a PDA detector. The data were analyzed
at 260 nm.2.12. GST and LO activity assays
2 ml of 0.1 M GSH were mixed with 10 ml of cytosolic or mi-
crosomal fraction (3.5 mg of proteins per ml) and 186 ml of phos-
phate buffer (0.1 M, pH¼6.5) in 96-well plate. The reaction was
started by the addition of 2 ml of 0.1 M CDNB. The GST-catalyzed
formation of GS-DNB was detected immediately at 340 nm every
minute for 15 min. LO activity was analyzed by Lipoxygenase In-
hibitor Screening Assay Kit (Abnova, Walnut, CA, USA) according to
the manufacturer's instructions. The reaction was initiated by
adding 5 ml of substrate (linoleic acid) to 50 ml of CCRF-CEM crude
extract (2.3 mg of proteins per ml) or 50 ml 15-lipoxygenase
standard solution (100% initial activity) and incubated for 10 min.
The enzyme catalysis was stopped by 50 ml of chromogen and the
absorbance was readied after 5 min at 490 nm.2.13. Cytotoxicity evaluation
The cytotoxicity of the tested compounds was assessed with
use of XTT cell proliferation kit II (Roche Diagnostics GmbH,
Mannheim, Germany) according to the manufacturer's instruc-
tions. Brieﬂy CCRF-CEM and BGM cells were seeded in a 96-well
plate at a density of 13,500 and 4000 cells per well, respectively.
After 24 h, the tested compounds were added to the culture media
and incubated for 72 h before the XTT dye was added. The ab-
sorbance at 495 nm was recorded after 1 h incubation with the
dye. IC50 values were determined by GraphPad Prism version 5.00
for Windows (GraphPad Software, La Jolla, CA, USA). Where in-
dicated, cells were preincubated with 50 mM BSO (GSH biosynth-
esis inhibitor) for 24 h prior to the addition of NCP.
Fig. 2. NCP effect on cell cycle in CCRF-CEM cells. Cells were incubated with 10–30 mM NCP for 24–72 h. The DNA content was measured by ﬂow cytometry and the
percentage of cell cycle distribution was analyzed by ModFit software. The data for 72 h incubation with 20 mM NCP and 48 h and 72 h incubation with 30 mM NCP are not
available due to extensive DNA fragmentation accompanying cell death. Representative histograms are shown in (A). The proportion of the cells in G1, S and G2/M phase
together with the statistical evaluation is depicted in (B). Data represent the means7SD, n¼3. *Po0.05 vs. untreated control (ANOVA).
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Unless otherwise indicated, the data are presented as means7
SD from at least 3 independent experiments. The differences be-
tween the individual treatments were analyzed by ANOVA with
Dunnett's post-hoc test (GraphPad Prism La Jolla, CA USA).3. Results
3.1. NCP triggers cell cycle arrest and apoptosis
Previous ﬁndings indicated a selective effect of NCP on cell
viability depending on the cell type [7]. In order to establish
whether the observed cytotoxicity was accompanied by a disrup-
tion of cell cycle and/or apoptosis induction, CCRF-CEM cells were
treated with 10–30 mM NCP –the concentrations near its IC50 from
the cytotoxicity assay (18.071.8 mM). DNA contents analysis re-
vealed that NCP induced cell cycle arrest in G2/M phase. The
proportion of the cells in G2/M phase increased 2 to 3-fold com-
pared to untreated control depending on the incubation condi-
tions (Fig. 2).
NCP also signiﬁcantly increased the percentage of Annexin
V-positive cells compared to untreated control (Fig. 3A, B). Im-
portantly, a distinct population of Annexin V-positive / PI-negative
(i.e. “early apoptotic”) cells was observed indicating a predominantlyFig. 3. NCP effect on apoptosis (AP) in CCRF-CEM cells. Cells were incubated with the in
control. The extent of apoptosis was evaluated using the Dead Cell Apoptosis Kit with An
Situ Marker (C). Representative dot plots are shown in (A). Upper-left quadrant: early (A
percentage of early and late apoptotic and necrotic cells together with the statistical evalu
control (ANOVA).apoptotic mode of cell death. This is further supported by the ac-
tivation of caspases (Fig. 3C). Although caspase activation followed a
clear concentration-dependent pattern at both 4 and 24 h, Annexin
V/PI assay was less sensitive at short incubation time (4 h) de-
monstrating a similar effect of 10–30 mM NCP. The results of both
assays were comparable at 24 h incubation period. Pre-treatment of
the cells with pan-caspase inhibitor Q-VD-OPh (10 mM) decreased
the percentage of total Annexin V-positive cells from 35% to 23%
indicating that caspases are at least partially involved in NCP-in-
duced cell death (Fig. 4). Given the previously identiﬁed GSH re-
activity with NCP [7], a possible role of GSH depletion in NCP-in-
duced apoptosis was investigated. Therefore, cells were pre-in-
cubated with GSH (3 mM) or N-acetylcysteine (3 mM) prior to the
addition of 20 mM NCP. Indeed, following the 24 h of incubation, the
percentage of the apoptotic cells in pre-treated samples decreased
by 30% compared to the samples treated with NCP only, i.e. to the
level of untreated control or even slightly below that level (Fig. 4).
3.2. NCP induces rapid GSH depletion accompanied by ROS produc-
tion and lipid peroxidation
A major effect of the antioxidants on the extent of the apoptosis
observed in NCP-treated CCRF-CEM cells led us to an investigation
of their oxidative status. It was found, that GSH level in NCP-
treated cells dropped to 3–65% of untreated control as early as
after 2–4 h of incubation depending on the concentration used. Atdicated concentration of NCP for 4 or 24 h. 1 mM staurosporine was used as positive
nexin V Alexa Fluors 488 & Propidium Iodide (A, B) or CaspACE™ FITC-VAD-FMK In
P); upper-right: late AP/necrosis; lower-left: viable cells; lower-right: necrosis. The
ation is showed in (B). Data represent the means7SD, n¼3. *Po0.05 vs. untreated
Fig. 4. The effect of thiols and caspase inhibition on NCP-induced apoptosis in CCRF-CEM cells. Cells pre-treated with GSH, NAC (both 3 mM) or pan-caspase inhibitor Q-VD-
OPh (10 mM) for 0.5 h were incubated with 20 mM NCP for 24 h. Dual annexin V/PI staining was used as in Fig. 3 to quantify the extent of apoptosis. Representative dot plots
are shown in (A). Upper-left quadrant: early (AP); upper-right: late AP/necrosis; lower-left: viable cells; lower-right: necrosis. Percentage of early and late apoptotic and
necrotic cells together with the statistical evaluation is showed in (B). Data represent the means7SD, n¼3. †Po0.05 vs. NCP (ANOVA).
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higher within the whole concentration range (Fig. 5A).
ROS level in NCP-treated cells followed a similar, only slightly
delayed pattern. ROS increase was detected already at 2 h of in-
cubation (9 to 14-fold), maximal values were reached at 4 h (260
to 500-fold) and dropped again near baseline at 24 h (Fig. 5B).
Accordingly, lipid peroxidation (measured as malondialdehydelevel) in NCP-treated cells was also on the highest increase after
4 h of incubation with NCP (Fig. 5D). Interestingly, NCP also
slightly but signiﬁcantly increased lipoxygenase activity (Fig. 5E).
Subsequently, the origin of ROS was investigated using various
inhibitors of ROS generation: CCCP (10 mM), DPI (10 mM), ABT
(0.25 mM), ALLO (0.5 mM), CAPE (10 mM) and 4-PBA (5 mM). The
antioxidants GSH (3 mM), NAC (3 mM) and QUER (10 mM) were
Fig. 5. NCP effect on the oxidative status of CCRF-CEM cells. Cells were incubated with the indicated concentration of NCP for 2–24 h (A, B, D) or alternatively, pre-treated
with speciﬁc antioxidants/inhibitors for 0.5 h prior to the addition of 20 mM NCP (C,E). GSH level in NCP-treated cells is expressed as the percentage of untreated control
(2.470.2 mM GSH/106 cells, A). ROS level in NCP-treated cells is expressed as the percentage of DCF ﬂuorescence intensity in untreated sample (B). The effect of inhibitors of
various metabolic pathways and antioxidants on NCP-induced ROS production (C). The effect of NCP on lipid peroxidation is expressed as the percentage of MDA in untreated
control (1.070.1 mM/106 cells, D). Lipoxygenase (LO) activity in NCP-treated cells is expressed as the percentage of untreated control (E). All data represent the means7SD,
n¼3. *Po0.05 vs. untreated control. †Po0.05 vs. NCP only (ANOVA).
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production was detected in the cells pre-treated with 4-PBA and
CAPE (Fig. 5C). An absolute reversion of ROS production was only
observed with the antioxidants. QUER, a free radical scavenger,
was signiﬁcantly less effective compared to the thiols (GSH, NAC).
This all suggests the provenance of ROS from multiple sources
with sulfhydryl depletion playing a major, initiating role while li-
pid peroxidation and ER stress are involved in further ROS
promotion.3.3. NCP activates Nrf2 pathway
Many recent reports demonstrate that glutathione depletion ac-
tivates Nrf2 pathway. An immunoblotting analysis of the nuclear
fraction of NCP-treated CCRF-CEM cells was performed to assess a
subcellular distribution of Nrf2. We found a rapid (0.5–1 h) translo-
cation of Nrf2 to the nuclei in response to NCP treatment (Fig. 6A).
Further, we investigated two Nrf2 downstream targets, NQO-1 and
GCLm. Following the 24 h treatment of the cells with NCP, both
Fig. 6. Activation of Nrf2- and ER stress-related pathways by NCP. Cells were incubated with the indicated concentration of NCP. After the incubation, nuclear fraction (A, 0–
4 h incubation), whole cell lysate (B, 24 h incubation) or membrane proteins (C, 0–4 h incubation) were resolved by SDS-PAGE and probed with speciﬁc antibodies. Den-
sitometric analysis is shown to the right of each Western blot. Results were normalized by arbitrarily setting the density of untreated cells to 100%. Data represent the
means7SD, n¼3. *Po0.05 vs. untreated control (ANOVA).
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(Fig. 6B).
3.4. NCP induces ER stress, mitochondrial depolarization and ATP
decrease
The role of ER stress in NCP-induced apoptosis was studied by
monitoring the activation of two major ER-stress related path-
ways, i.e. eIE2α and IRE1. The results showed that NCP (20 mM)
induced an early increase in the phosphorylation of both proteins
(Fig. 6C) suggesting the presence of ER stress.
With respect to the known fact that NCP undergoes GST-cata-
lyzed conjugation with the GSH, we have determined the con-
tribution of the microsomal and the cytosolic GSTs aiming to
evaluate the role of local GSH decrease directly in the ER to the
development of ER stress. To this end, subcellular fractions isolated
from untreated CCRF-CEM cells were employed. Following the
incubation of the respective fractions with 20–200 mM NCP and0.5 mM GSH for 30 min, we found 100% conversion in the cytosol
vs. no conversion in the microsomes. To avoid false negative re-
sults the GST activity in both fractions was measured using CDNB
as a substrate and was found to be 5587113 ncat/mg in the cy-
tosol and 72727 ncat/mg in the microsomes.
To further examine whether the NCP-induced oxidative and ER
stress also affects mitochondria, MMP was determined. It was
found that NCP caused a time- and concentration-dependent MMP
loss (Fig. 7A). The pre-treatment of the cells with 5 mM 4-PBA (an
ER stress inhibitor) abolished this effect at 4 h but not at 24 h
because of its inherent cytotoxic effect at longer incubation times
(data not shown). On the other hand, the pre-treatment of the
cells with antioxidants, GSH (3 mM) and NAC (3 mM), prevented
the MMP loss for up to 24 h incubation (Fig. 7B).
The ATP level following the 2–24 h of NCP treatment corre-
sponded well with mitochondria condition. Intracellular ATP
concentrations decreased for up to 25% compared to untreated
control (Fig. 7C). The effect of NCP on mitochondrial ROS was also
Fig. 7. NCP effect on mitochondrial function in CCRF-CEM cells. Cells were incubated with the indicated concentration of NCP for 2–24 h (A,C,D) or pre-treated with speciﬁc
inhibitors for 0.5 h prior to the addition of 20 mM NCP for 4 h (B). Mitochondrial membrane potential (MMP) was determined with the use of JC-1 probe and ﬂow cytometric
detection. The data are presented as the percentage of de-energized mitochondria (A, B). The ATP level in NCP-treated cells was quantiﬁed by CellTiter-Glos assay (C). The
absolute value of ATP in untreated sample¼4.270.1 mM. Mitochondrial superoxides were detected with the use of MitoSOX™ probe and quantiﬁed by ﬂow cytometry (D).
The data are expressed as the percentage of untreated control (100%) and represent means7SD, n¼3. *Po0.05 vs. untreated control. †Po0.05 vs. NCP only (ANOVA).
Table 1
Effect of chloropurine-caused GSH depletion on cytotoxicity in CCRF-CEM and BGM cells.
Comp. CCRF-CEM BGM
GSH decrease (%)a GSH decrease EC50 (mM)b Cell viability (%)c Cell viability IC50 (mM)d GSH decrease (%)a Cell viability (%)c Cell viability IC50 (mM)d
1 (NCP) 873 4.570.1 1678 18.071.8 62717 11176 Z50
2 1273 4.970.1 35710 23.371.6 57710 96718 Z50
3 1173 6.871.6 50711 22.170.7 58714 104710 Z50
4 773 2.770.1 971 7.670.4 60711 10676 Z50
5 170 4.971.3 1576 16.672.2 61718 104711 Z50
6 472 3.270.1 1174 7.970.4 5477 109710 Z50
7 371 4.570.5 871 11.170.8 70711 10175 Z50
8 7673 NA 10778 Z50 73711 11674 Z50
9 7578 NA 91711 Z50 82714 9875 Z50
Data are means7SD from three independent experiments. Control (BGM)¼6.570.8 mM GSH/106 cells. Control (CCRF-CEM)¼2.470.2 mM GSH/106 cells.
a 4 h treatment with 20 mM compounds; untreated control¼100% GSH.
b EC50 value indicates the concentration of a compound causing 50% decrease in cellular GSH content after 4 h incubation (calculated using the non-linear regression
method by GraphPad Prism).
c 72 h treatment with 20 mM compounds; untreated control¼100% viability.
d IC50 value indicates the concentration of a compound causing 50% decrease in cells viability in XTT assay after 72 h incubation (calculated using the non-linear
regression method by GraphPad Prism).
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to 1.5-fold after 24 h (but not 4 h) incubation with 20 mM NCP
indicating the (secondary) mitochondrial damage (Fig. 7D).
3.5. Cytotoxicity of 9-norbornyl-6-chloropurine derivatives corre-
lates with their GSH-depleting potency
To provide evidence that the observed cellular effects of NCP
ultimately leading to the apoptotic cell death are indeed GSH-
dependent, we assayed a series of 8 additional 9-norbornylpurine
derivatives (Fig. 1) for their cytotoxicity and the effect on GSH level
in both leukemia (CCRF-CEM) and normal epithelial (BGM) cells. It
was found, that GSH level in treated cells dropped to 1–76% of
untreated control in CCRF-CEM cells after 4 h of incubation. Im-
portantly, the derivatives lacking the GSH-lowering capacity were
also the least cytotoxic of the group (Table 1). Interestingly, both
inactive derivatives (8 and 9) are substituted at the position 8.
Other modiﬁcations (on both norbornane moiety or purine ring)
apparently did not make a signiﬁcant impact on the biological
activity. Compounds 2–7 were all capable of a marked and rapid
depletion of GSH pool and were also cytotoxic in CCRF-CEM cells.
However, EC50 titration for GSH-lowering capacity revealed subtle
differences among the compounds, which largely correlate with
their cytotoxic IC50.
The decrease of GSH level in BGM cells ranged between 54%
and 82% (Table 1). No cytotoxicity was observed, when BGM cells
were treated with 20 mM compounds. Their IC50 for a cytotoxic
effect exceeded the maximal tested concentration of compounds
(50 mM) (Table 1).4. Discussion
9-Norbornyl-6-chloropurines (Fig. 1) are a novel class of anti-
viral and cytotoxic compounds. NCP, a representative structure
within this class, has been previously identiﬁed as a promising
antileukemic agent because of its highly selective cytotoxicity to-
wards leukemia cell lines (IC50 20 mM) vs. solid tumor cell lines
(IC50 150 mM) or noncancerous cells (IC50 500 mM) [7]. We
here provide evidence that the compound induces apoptotic cell
death through NCP-triggered GSH depletion.
As described previously, NCP was shown to be a substrate for
GST, forming a GSH conjugate (NCP-GS) as a major metabolite that
is excreted from the cells [7]. Reduced GSH is the most abundant
low molecular weight thiol in animal cells and is involved in many
cellular processes [26]. Also, GSH is the main redox buffer in the
cells and GSH/GSSG ratio is an accepted indicator of intracellular
redox status [27]. We found that GSH level was rapidly decreased
in NCP-treated cells, but it was also quickly replenished by 24 h of
incubation (Fig. 5A). As expected, ROS level followed a com-
plementary pattern i.e. an initial increase that was followed by a
drop near baseline (Fig. 5B). MDA levels remained elevated at 24 h,
which is not particularly surprising since it is a relatively stable
oxidation product with considerably higher half-life compared to
ROS. A fast cellular response to NCP-induced oxidative stress
suggested an activation of antioxidant defense system [28,29].
Indeed, we have observed a rapid activation of Nrf2 pathway as
documented by phosphorylation and a translocation of Nrf2 to
nuclei (Fig. 6A). This was associated with an induction of Nrf2
downstream targets, such as NQO-1 and GCLm (Fig. 6B). The latter
directly explains the observed restoration of GSH level to basal
conditions or even higher than that. Despite the early activation of
the antioxidant signalling, NCP still triggered apoptosis in CCRF-
CEM cells (Fig. 3). The induction of cell death by NCP may indicate
that the repair mechanisms have been overwhelmed by the critical
amount of ROS as previously suggested by others [30,31]. The factthat the GSH- or NAC-pretreated cells remained resistant to the
cytotoxic/apoptotic effects of NCP (Fig. 4) points to an essential
role of GSH in the apoptotic signalling induced by NCP.
ROS have been known to activate ER apoptotic death pathways
[32] and ER-associated stress allows ROS to be generated by the
mitochondria contributing to mitochondria-associated cell death
[33]. Also, mitochondria-associated ROS in return may enhance ER
stress response [34]. A number of compounds have been reported
to induce apoptosis in various cells through both ER and mi-
tochondrial pathways, e.g. curcumin or furanodien [35,36]. We
have shown that NCP affects mitochondria by inducing MMP loss,
ATP production decrease and mitochondrial superoxide genera-
tion (Fig. 7A, C, D). We also demonstrated that NCP induced PERK/
eIF2α and IRE1 phosphorylation clearly indicating the activation of
at least two pathways of the unfolded protein response (Fig. 6C).
Moreover, the inhibition of ER stress by 4-PBA reversed mi-
tochondrial depolarization induced by NCP. Similar effect was
observed with the antioxidants NAC and GSH, again pointing to a
key role of GSH level in NCP-induced cellular effects (Fig. 7B). In
addition, 4-PBA was also effective in inhibiting NCP-induced ROS
generation surpassing the effect of quercetin, the known inhibitor
of lipid peroxidation and potent antioxidant. However, quercetin
also reacts with cellular thiols [37], which may explain its weak
protection against NCP-induced ROS production. Notably, NCP was
not a substrate for the microsomal GSTs suggesting that the pre-
sumed loss of local (microsomal) GSH is not the direct trigger for
ER stress development.
Interestingly, lipoxygenase (LO) inhibitor CAPE was found to be
very effective in ROS inhibition (Fig. 5C). 5-LO was indeed slightly
activated by the action of NCP and CAPE prevented this effect,
however, it seems unlikely that this would be the major factor de-
termining such a huge protectivity against NCP-induced ROS in-
crease. In fact, the effects of CAPE on the cells are rather pleiotropic.
In addition to LO inhibition, it is also a known radical scavenger and a
compound with anti-inﬂammatory effects [38,39]. Therefore, several
events could contribute to its overall protective effect. GSH redox
system and mitochondrial dysfunction have crucial role in the reg-
ulation of cell cycle as well [40–42]. NCP was found to cause con-
centration- and time-dependent cell cycle arrest in G2/M phase,
which is apparently tightly connected with the apoptotic potency of
NCP (Fig. 2). G2/M phase arrest has also been reported in several cell
lines for another GSH-reactive anticancer compound – sulphor-
aphane [43]. NCP-induced cell death has been shown to be caspase-
mediated, although other mechanisms seem to be also involved. The
apparent inconsistency of the data pointing to the actual increase in
late apoptotic population following the caspase inhibition, can be
explained by the fact that using the Annexin V/PI assay it is not
possible to distinguish between late apoptotic and necrotic cells. It is
therefore likely that the inhibition of caspases drives NCP-induced
cell death towards necrosis rather than apoptosis.
To date, a combination chemotherapy rather than a single agent
treatment is the standard in clinical practice. Whereas elevated GSH
levels are associated with tumor cell resistance [44], depletion of
intracellular GSH has been recognized to result in enhanced toxicity
of various chemotherapeutic agents in drug-resistant tumors. For
example, N-methylformamide improved the response of colon can-
cer cells to doxorubicin and cisplatin [45]. Also, pre-treatment of the
antihormone-resistant breast cancer cells with buthionine sulfox-
imine was found to increase their sensitivity to estradiol-induced
apoptosis [46]. The capacity of NCP to decrease GSH level, induce
ROS overproduction, ER stress and mitochondrial dysfunction may
therefore be especially advantageous in various combination regi-
mens. On the other hand, sustained low doses of NCP that do not
induce apoptosis could be eventually chemoprotective due to its
ability to induce Nrf2 pathway and boost cellular antioxidant de-
fense. Also in this respect, NCP appears to resemble the natural
P. Plačková et al. / Free Radical Biology and Medicine 97 (2016) 223–235234isothiocyanate sulphoraphane. This particular property of NCP may
also be responsible for its relatively high (micromolar) IC50 in the
cytotoxicity assay.
To address the question whether the cytotoxicity correlated with
GSH levels in treated cells, a panel of variously substituted 9-nor-
bornyl-6-chloropurines was employed (Fig. 1). Apart from leukemia
CCRF-CEM cells, BGM kidney epithelial cells, commonly used for
antiviral screening, were included to this experiment. Using these
cells, connection between the depletion of intracellular GSH and
defective virion morphogenesis of enteroviruses has been previously
demonstrated [47]. All compounds used in this study except for
8-substituted compounds (8 and 9) lowered cellular GSH with si-
milar (good) efﬁciency (Table 1). Obviously, substitution at the po-
sition 8 completely abolished both cytotoxicity and the capacity of
the compounds to modulate GSH level in the cells. This is likely due
to the impaired interaction of these compounds with GST - we found
that non-enzymatic conjugation of NCP with the GSH was negligible
[7]. The drop in GSH level caused by 9-norbornyl-6-chloropurines
was smaller in BGM than that in CCRF-CEM cells (Table 1) and the
viability of BGM cells remained unaffected. These results can be
explained by a different basal level of GSH in these two cell lines,
which was almost three times higher in BGM than in CCRF-CEM
cells. Although we can expect equivalent loss of GSH in both CCRF-
CEM and BGM cells due to its interaction with the same amount of
the inhibitor (20 mM), the levels of remaining GSH will be different.
Whilst this residual GSH does not cover the needs of the CCRF-CEM
cells, in case of BGM cells it is still sufﬁcient to protect them from
oxidative stress. Moreover, cytotoxic effect of 9-norbornyl-6-chlor-
opurines in CCRF-CEM cells can be pronounced by a very low activity
of catalase in this cell line [48]. Therefore, we can conclude that the
ability of norbornylpurines to lower GSH is critical for inducing cell
death. Interestingly, various substitutions on the norbornane moiety
did not make remarkable difference in compounds ability to inﬂu-
ence cell viability or GSH level. Subtle differences observed among
the series more likely result from their distinct physico-chemical
properties e.g. lipophilicity, thus affecting membrane permeability
and cellular uptake.
In summary, we described the key role of GSH depletion in NCP-
induced cell death through ER stress activation and mitochondrial
dysfunction. Furthermore, NCP was found to overcome cellular de-
fense mechanisms at longer incubation times or high concentrations
used and thus inducing G2/M arrest and apoptosis. Our data suggest
the potential of NCP as a novel antileukemic drug, especially in
combination chemotherapy and provides important information
regarding the development of a GSH-depleting strategy.Conﬂict of interest
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